FDA Inspection 615933 — Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
The FDA completed an inspection of Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. on September 17, 2009 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 17, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)